Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



THOMAS FRANK E Create: Alert

All | News | Filings
Date FiledTypeDescription
10/10/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/11/2023 4 THOMAS FRANK E (Director) has filed a Form 4 on Larimar Therapeutics, Inc.
Txns: Granted 8,300 options to buy @ $5.09, valued at $42.2k
03/14/2023 4 THOMAS FRANK E (See Remarks) has filed a Form 4 on Orchard Therapeutics plc
Txns: Exercised 20,000 options to buy @ $0.4591, valued at $9.2k
02/13/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/19/2022 4 THOMAS FRANK E (Director) has filed a Form 4 on Spero Therapeutics, Inc.
Txns: Granted 15,000 shares @ $0
06/03/2022 4 THOMAS FRANK E (See Remarks) has filed a Form 4 on Orchard Therapeutics plc
Txns: Granted 375,000 options to buy @ $0.4591, valued at $172.2k
05/12/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/04/2022 4 THOMAS FRANK E (See Remarks) has filed a Form 4 on Orchard Therapeutics plc
Txns: Bought 10,000 shares @ $0.7474, valued at $7.5k
01/07/2022 4 THOMAS FRANK E (Director) has filed a Form 4 on Spero Therapeutics, Inc.
Txns: Granted 2,214 options to buy @ $13.19, valued at $29.2k
08/18/2021 4 THOMAS FRANK E (Director) has filed a Form 4 on Spero Therapeutics, Inc.
Txns: Granted 7,500 options to buy @ $13.69, valued at $102.7k
05/17/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/03/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/01/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/12/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/06/2021 4 THOMAS FRANK E (Director) has filed a Form 4 on Spero Therapeutics, Inc.
Txns: Granted 1,314 options to buy @ $17.93, valued at $23.6k
10/27/2020 4 THOMAS FRANK E (Director) has filed a Form 4 on Spero Therapeutics, Inc.
Txns: Granted 7,500 options to buy @ $13.52, valued at $101.4k
09/30/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/15/2020 4 THOMAS FRANK E (See Remarks) has filed a Form 4 on Orchard Therapeutics plc
Txns: Exercised 10,000 options to buy @ $2.44, valued at $24.4k
04/03/2020 4 THOMAS FRANK E (See Remarks) has filed a Form 4 on Orchard Therapeutics plc
Txns: Granted 150,000 options to buy @ $7.05, valued at $1.1M
01/06/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/06/2020 4 THOMAS FRANK E (See Remarks) has filed a Form 4 on Orchard Therapeutics plc
Txns: Granted 200,000 options to buy @ $13.58, valued at $2.7M
01/02/2020 3 THOMAS FRANK E (See Remarks) has filed a Form 3 on Orchard Therapeutics plc
06/27/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/05/2019 4 THOMAS FRANK E (Director) has filed a Form 4 on Spero Therapeutics, Inc.
Txns: Granted 6,073 options to buy @ $10.67, valued at $64.8k
06/07/2018 4 THOMAS FRANK E (Director) has filed a Form 4 on ZAFGEN, INC.
Txns: Granted 20,000 options to buy @ $6.79, valued at $135.8k
06/06/2018 4 THOMAS FRANK E (Director) has filed a Form 4 on Spero Therapeutics, Inc.
Txns: Granted 6,073 options to buy @ $11.54, valued at $70.1k
11/01/2017 3 THOMAS FRANK E (Director) has filed a Form 3 on Spero Therapeutics, Inc.
06/23/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
02/27/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
07/01/2016 4 THOMAS FRANK E (Director) has filed a Form 4 on ZAFGEN, INC.
Txns: Granted 12,000 options to buy @ $5.99, valued at $71.9k
03/01/2016 4 THOMAS FRANK E (President & COO) has filed a Form 4 on AMAG PHARMACEUTICALS INC.
Txns: Paid exercise price by delivering 7,417 shares @ $27.01, valued at $200.3k
Paid exercise price by delivering 1,361 shares @ $27.01, valued at $36.8k
Paid exercise price by delivering 458 shares @ $27.01, valued at $12.4k
Paid exercise price by delivering 515 shares @ $26.28, valued at $13.5k
Granted 17,000 shares @ $0
Granted 40,000 options to buy @ $25.18, valued at $1M
08/21/2015 4 THOMAS FRANK E (President & COO) has filed a Form 4 on AMAG PHARMACEUTICALS INC.
Txns: Paid exercise price by delivering 2,363 shares @ $61.71, valued at $145.8k
08/07/2015 4 THOMAS FRANK E (President & COO) has filed a Form 4 on AMAG PHARMACEUTICALS INC.
Txns: Sold 15,000 shares @ $66.85, valued at $1M
Exercised 15,000 options to buy @ $14.91, valued at $223.7k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy